Product Images Leafpro Cbdmed Oil T-fs Qd 3%

Leafpharma Inc. distributes CBDmed Oil with cannabidiol that provides pain-relieving, anti-inflammatory, soothing, and relaxing effects. This product has an NDC code of 73674-020-01 and comes in 10 mL/0.34 fl oz bottle with directions on the carton. The product is intended for oral use only and should be stored at 15-25°C (59-77°F).*

This is a description of a product called "leafPro CBDmed Spray" distributed by Leafpharma Inc. The product comes in a 30ml/1.01floz bottle and contains cannabidiol. It has pain-relieving, anti-inflammatory, soothing, and relaxing effects. This product is for oral use only and should be stored at 15-25°C (59-77°F). The directions for use are located on the carton. The National Drug Code (NDC) for this product is 73674-020-02.*

leafPro CBDmed Oil is a cannabidiol-based product that aims to provide soothing and relaxing effects, relieve pain, and reduce inflammation. The product contains 3% of cannabidiol and is distributed by LeafPharma Inc. The recommended dosage of the product is 1-3 drops under the tongue for adults and children over 12 years old. It is essential to avoid alcoholic drinks and be cautious when driving or operating machinery when using the product. Possible side effects include sleepiness, increased liver enzymes, and feeling very tired and weak. In case of hypersensitivity or other side effects, consult a medical professional.*

This is a drug facts label for a product that contains 3% cannabidiol, an anti-inflammatory, an analgesic and a sedative. It is used for pain relief, and soothing and relaxing effect. The label provides warnings, directions, and describes possible side effects, including sleepiness, an increase in liver enzymes, feeling very tired and weak. It also gives important information about storing the product and protecting it from excessive moisture and direct sunlight. The product has inactive ingredients that include Full Spectrum Hemp extract (THC-free) and MCT Coconut oil. The label provides contact information for questions and comments.*